tradingkey.logo

CeriBell Inc

CBLL
20.150USD
+0.810+4.19%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
746.53MMarktkapitalisierung
VerlustKGV TTM

CeriBell Inc

20.150
+0.810+4.19%

mehr Informationen über CeriBell Inc Unternehmen

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

CeriBell Inc Informationen

BörsenkürzelCBLL
Name des UnternehmensCeribell Inc
IPO-datumOct 11, 2024
CEOChao (Xingjuan)
Anzahl der mitarbeiter281
WertpapierartOrdinary Share
GeschäftsjahresendeOct 11
Addresse360 N. Pastoria Avenue
StadtSUNNYVALE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94085
Telefon18004360826
Websitehttps://ceribell.com/
BörsenkürzelCBLL
IPO-datumOct 11, 2024
CEOChao (Xingjuan)

Führungskräfte von CeriBell Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+6618.00%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.04M
-54000.00%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
483.50K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
87.99K
--
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+6618.00%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.04M
-54000.00%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
483.50K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
87.99K
--
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
EEG headbands, point in time
17.02M
75.35%
EEG portal and Clarity subscriptions, over time
5.57M
24.65%
Nach RegionUSD
Name
Umsatz
Anteil
United States
22.59M
100.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
EEG headbands, point in time
17.02M
75.35%
EEG portal and Clarity subscriptions, over time
5.57M
24.65%

Aktionärsstatistik

Aktualisiert: 17 hours ago
Aktualisiert: 17 hours ago
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
Andere
58.67%
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
Andere
58.67%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
39.59%
Investment Advisor/Hedge Fund
20.38%
Private Equity
10.70%
Individual Investor
10.34%
Venture Capital
6.71%
Hedge Fund
4.41%
Research Firm
1.48%
Pension Fund
0.36%
Bank and Trust
0.21%
Andere
5.82%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
202
30.92M
84.91%
-28.12K
2025Q3
202
30.95M
85.03%
-25.06K
2025Q2
178
30.95M
75.12%
+1.98M
2025Q1
151
30.66M
70.71%
+5.27M
2024Q4
110
29.39M
58.97%
+8.25M

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fidelity Management & Research Company LLC
4.31M
11.63%
-376.91K
-8.04%
Sep 30, 2025
TPG Capital, L.P.
3.97M
10.7%
--
--
Sep 30, 2025
Longitude Capital Management Co., LLC
2.48M
6.67%
+2.48M
--
Oct 16, 2024
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.38%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
5.95%
--
--
Sep 30, 2025
Parvizi (Josef)
2.09M
5.64%
+6.62K
+0.32%
Apr 11, 2025
Ally Bridge Group (HK) Limited
1.69M
4.56%
-750.00K
-30.72%
Dec 09, 2025
BlackRock Institutional Trust Company, N.A.
1.52M
4.09%
+146.63K
+10.70%
Sep 30, 2025
The Vanguard Group, Inc.
1.47M
3.97%
+147.01K
+11.09%
Sep 30, 2025
Chao (Xingjuan)
1.10M
2.96%
--
--
Dec 04, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Neuroscience and Healthcare ETF
0.57%
Hypatia Women CEO ETF
0.5%
Fidelity Fundamental Small-Mid Cap ETF
0.1%
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Mehr Anzeigen
iShares Neuroscience and Healthcare ETF
Anteil0.57%
Hypatia Women CEO ETF
Anteil0.5%
Fidelity Fundamental Small-Mid Cap ETF
Anteil0.1%
iShares Micro-Cap ETF
Anteil0.06%
ProShares Hedge Replication ETF
Anteil0.02%
iShares Russell 2000 Growth ETF
Anteil0.02%
ProShares UltraPro Russell2000
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
Schwab U.S. Small-Cap ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI